Techno Drugs Ltd. (DSE:TECHNODRUG)
Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
29.70
+0.20 (0.68%)
At close: Mar 4, 2026

Techno Drugs Income Statement

Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22
3,1503,3763,6132,7335,029
Revenue Growth (YoY)
5.24%-6.58%32.19%-45.64%-
Cost of Revenue
1,7861,9192,0981,5793,224
Gross Profit
1,3641,4571,5151,1541,804
Selling, General & Admin
679.11758.69848.23628.04905.09
Operating Expenses
679.11758.69848.23628.04905.09
Operating Income
684.9698.33666.8526899.4
Interest Expense
-422.44-411.48-305.93-263.87-256.61
Interest & Investment Income
1.851.852.552.6211.97
Currency Exchange Gain (Loss)
---0.19-0.01-
Other Non Operating Income (Expenses)
-2.51-1.86-3.64-5.69-3.74
Pretax Income
261.8286.83359.59259.05651.02
Income Tax Expense
56.2654.8178.9963.55171.24
Net Income
205.53232.02280.6195.51479.78
Net Income to Common
205.53232.02280.6195.51479.78
Net Income Growth
-6.04%-17.31%43.53%-59.25%-
Shares Outstanding (Basic)
132132959494
Shares Outstanding (Diluted)
132132959494
Shares Change (YoY)
15.69%38.07%1.34%--
EPS (Basic)
1.561.762.942.085.10
EPS (Diluted)
1.561.762.942.085.10
EPS Growth
-18.78%-40.11%41.62%-59.25%-
Free Cash Flow
-141.96-479.5283.64-416.28-1.52
Free Cash Flow Per Share
-1.07-3.640.88-4.42-0.02
Dividend Per Share
-1.0001.200--
Dividend Growth
--16.67%---
Gross Margin
43.30%43.16%41.93%42.22%35.88%
Operating Margin
21.74%20.69%18.45%19.24%17.89%
Profit Margin
6.53%6.87%7.77%7.15%9.54%
Free Cash Flow Margin
-4.51%-14.21%2.31%-15.23%-0.03%
EBITDA
1,0551,053990.74817.361,151
EBITDA Margin
33.48%31.19%27.42%29.90%22.89%
D&A For EBITDA
369.61354.38323.94291.35251.54
EBIT
684.9698.33666.8526899.4
EBIT Margin
21.74%20.69%18.45%19.24%17.89%
Effective Tax Rate
21.49%19.11%21.97%24.53%26.30%
Advertising Expenses
-1.370.760.260.59
Source: S&P Global Market Intelligence. Standard template. Financial Sources.